RPG LifeScience.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE105J01010
  • NSEID: RPGLIFE
  • BSEID: 532983
INR
2,196.50
-4.25 (-0.19%)
BSENSE

Dec 05

BSE+NSE Vol: 4.28 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 3.84% vs 12.04% in Sep 2024

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 103.94% vs -35.45% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is -12.35% vs 22.25% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is -21.88% vs 88.24% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has fallen from Sep 2024

Compare Half Yearly Results Of RPG LifeScience. With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
350.60
123.16
227.44
184.67%
Other Operating Income
0.00
0.00
0.00
Total Operating income
350.60
123.16
227.44
184.67%
Raw Material Cost
64.76
24.40
40.36
165.41%
Purchase of Finished goods
71.84
0.00
71.84
(Increase) / Decrease In Stocks
-10.00
-0.78
-9.22
-1,182.05%
Employee Cost
69.86
44.02
25.84
58.70%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
79.64
47.68
31.96
67.03%
Total Expenditure (Excl Depreciation)
276.10
115.32
160.78
139.42%
Operating Profit (PBDIT) excl Other Income
74.50
7.84
66.66
850.26%
Other Income
9.77
48.59
-38.82
-79.89%
Operating Profit (PBDIT)
84.27
56.43
27.84
49.34%
Interest
0.25
40.87
-40.62
-99.39%
Exceptional Items
11.22
0.00
11.22
Gross Profit (PBDT)
95.24
15.56
79.68
512.08%
Depreciation
10.36
32.26
-21.90
-67.89%
Profit Before Tax
84.88
-16.70
101.58
608.26%
Tax
21.74
-5.77
27.51
476.78%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
63.14
-10.93
74.07
677.68%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
63.14
-10.93
74.07
677.68%
Equity Capital
13.23
31.36
-18.13
-57.81%
Face Value
8.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
38.18
-0.70
38.88
5,554.29%
Diluted Earnings per share
38.18
-0.70
38.88
5,554.29%
Operating Profit Margin (Excl OI)
21.25%
6.37%
0.00
14.88%
Gross Profit Margin
27.16%
12.63%
0.00
14.53%
PAT Margin
18.01%
-8.87%
0.00
26.88%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 350.60 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 3.84% vs 12.04% in Sep 2024

Half Yearly - Standalone Net Profit
Standalone Net Profit 63.14 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 103.94% vs -35.45% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 74.50 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -12.35% vs 22.25% in Sep 2024

Half Yearly - Interest
Interest 0.25 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -21.88% vs 88.24% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.25%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has fallen from Sep 2024